The Lancet journal group recently published three research articles looking at how Aspirin can impact on the incidence of cancer, the spread of cancer, and actual cancer deaths. The work was done at Oxford University, by a team headed by Peter M. Rothwell. Their work has interesting implications.
First, aspirin appears to reduce the short-term risks of both incidence of cancer and mortality. In this study, the risk of cancer seemed to be some 37% lower if individuals were taking aspirin, compared to the control group.
The second article provided information that suggests that aspirin prevents metastasis, or the spread of cancerous cells to other parts of the body. This would make a cancer easier to treat and likely increase a patient’s chances of surviving. Data suggested that patients who took aspirin were 46% less likely to have their cancer spread, as compared to those in the control group. There were additional statistics relating to spread and mortality.
It is important to note that these studies were not specifically designed to test the effects of aspirin on cancers, so further research must follow. Aspirin is not yet recommended as a means of preventing cancer, and are no indications that it should be taken as a precautionary measure at this time. Remember that there can be serious side effects of taking aspirin, so these initial results should not be reason for you to start taking aspirin.
Aspirin can potentially cause harmful effects, such as a risk of stomach irritation and bleeding. There is a greater risk in people who have had stomach ulcers, the elderly, and those who take drugs or have other medical conditions that increase their risk of bleeding. For some, aspirin can affect breathing or create allergic reactions. Aspirin is an effective medicine proven to be highly useful in specific treatments, and its potential uses appear to be expanding. Still, it is not yet time to take aspirin without medical advice on a daily basis, even at low doses.